Statements (97)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:alternativeName |
gptkb:MSD_(outside_United_States_and_Canada)
|
| gptkbp:CEO |
gptkb:Robert_M._Davis
|
| gptkbp:founded |
1891
|
| gptkbp:founder |
gptkb:George_Merck
|
| gptkbp:headquartersLocation |
gptkb:Kenilworth,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Merck & Co.
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:netIncome |
$7.3 billion (2023)
|
| gptkbp:notableEvent |
Avelox approved for bacterial infections
Bridion approved for anesthesia reversal Clarinex approved for allergies Cosopt approved for glaucoma Cozaar approved for hypertension Crixivan approved for HIV Cubicin approved for bacterial infections Emend approved for nausea and vomiting Fosamax approved for osteoporosis Gardasil approved for HPV prevention Invanz approved for bacterial infections Isentress approved for HIV Januvia approved for type 2 diabetes Keytruda approved for multiple cancer types Lenvima approved for thyroid cancer Lynparza approved for ovarian cancer Mevacor approved for high cholesterol Noxafil approved for fungal infections Pepcid approved for ulcers and GERD Primaxin approved for bacterial infections Propecia approved for hair loss Proscar approved for benign prostatic hyperplasia Recarbrio approved for bacterial infections Remicade approved for autoimmune diseases Simponi approved for autoimmune diseases Singulair approved for asthma Steglatro approved for type 2 diabetes Timoptic approved for glaucoma Trusopt approved for glaucoma Vasotec approved for hypertension Victrelis approved for hepatitis C Vytorin approved for high cholesterol Zocor approved for high cholesterol Zolinza approved for cutaneous T-cell lymphoma acquired Schering-Plough in 2009 developed first HPV vaccine developed first hepatitis B vaccine developed first measles vaccine developed first mumps vaccine developed first rubella vaccine developed ivermectin for river blindness involved in Vioxx litigation spun off Organon in 2021 |
| gptkbp:numberOfEmployees |
approximately 69,000 (2023)
|
| gptkbp:parentCompany |
independent
|
| gptkbp:product |
gptkb:Lynparza
gptkb:Avelox gptkb:Bridion gptkb:Clarinex gptkb:Cosopt gptkb:Cozaar gptkb:Crixivan gptkb:Cubicin gptkb:Emend gptkb:Fosamax gptkb:Gardasil gptkb:Invanz gptkb:Isentress gptkb:Januvia gptkb:Keytruda gptkb:Lenvima gptkb:Mevacor gptkb:Noxafil gptkb:Pepcid gptkb:Primaxin gptkb:Propecia gptkb:Proscar gptkb:Recarbrio gptkb:Remicade gptkb:Simponi gptkb:Singulair gptkb:Steglatro gptkb:Timoptic gptkb:Trusopt gptkb:Vasotec gptkb:Victrelis gptkb:Vytorin gptkb:Zetia gptkb:Zocor gptkb:Zolinza |
| gptkbp:revenue |
$59.3 billion (2023)
|
| gptkbp:stockExchange |
gptkb:NYSE
|
| gptkbp:stockSymbol |
gptkb:MRK
|
| gptkbp:subsidiary |
gptkb:Merck_Research_Laboratories
gptkb:MSD_Animal_Health |
| gptkbp:website |
https://www.merck.com/
|
| gptkbp:bfsParent |
gptkb:award
|
| gptkbp:bfsLayer |
3
|